Table 3.
Anthropometric variables of the study population as divided by Gensini score groups
| Variables | Total | Gensini score; n(%) | Mean ± SD | P-Value | |||
|---|---|---|---|---|---|---|---|
| < 7 | > = 7 | P-value | |||||
| Gender (frequency, percentile) | Male | 606 | 155(25.6%) | 451(74.4%) | < 0.001 | 28.13 ± 28.21 | < 0.001 |
| Female | 402 | 159(39.6%) | 243(60.4%) | 21.35 ± 27.86 | |||
| Age groups (years) | < 40 | 51 | 33(64.7%) | 18(35.3%) | < 0.001 | 6.91 ± 10.48 | < 0.001 |
| 40–49 | 175 | 83(47.4%) | 92(52.6%) | 14.97 ± 19.16 | |||
| 50–59 | 385 | 109(28.3%) | 276(71.7%) | 27.45 ± 29.35 | |||
| 60–69 | 261 | 66(25.3%) | 195(74.7%) | 27.68 ± 29.61 | |||
| > = 70 | 136 | 23(16.9%) | 113(83.1%) | 35.80 ± 30.03 | |||
| HTN (frequency, percentile) | Yes | 635 | 169(26.6%) | 466(73.4%) | < 0.001 | 27.64 ± 28.91 | 0.001 |
| No | 372 | 145(39.0%) | 227(61.0%) | 21.56 ± 26.70 | |||
| DM (frequency, percentile) | Yes-Insulin | 108 | 26(24.1%) | 82(75.9%) | 0.009 | 31.85 ± 31.30 | < 0.001 |
| noninsulin | 283 | 74(26.1%) | 209(73.9%) | 29.65 ± 31.18 | |||
| no | 617 | 214(34.7%) | 403(65.3%) | 22.37 ± 25.79 | |||
| DM (frequency, percentile) | Yes | 391 | 100(25.6%) | 291(74.4%) | 0.002 | 30.26 ± 31.19 | < 0.001 |
| No | 617 | 214(34.7%) | 403(65.3%) | 22.37 ± 25.79 | |||
| CABG or PCI | Yes | 111 | 27(24.3%) | 84(75.7%) | 0.098 | 25.69 ± 30.29 | 0.881 |
| No | 883 | 283(32.0%) | 600(68.0%) | 25.26 ± 27.82 | |||
| ACS or HF | Yes | 439 | 107(24.4%) | 332(75.6%) | < 0.001 | 29.46 ± 30.54 | 0.000 |
| No | 569 | 207(36.4%) | 362(63.6%) | 22.32 ± 25.97 | |||
| FH of premature CAD (frequency, percentile) | Yes | 583 | 188(32.2%) | 395(67.8%) | 0.379 | 24.86 ± 28.71 | 0.456 |
| No | 425 | 126(29.6%) | 299(70.4%) | 26.20 ± 27.64 | |||
| Smoker (frequency, percentile) | Yes | 157 | 37(23.6%) | 120(76.4%) | 0.025 | 26.63 ± 25.69 | .554 |
| No | 850 | 277(32.6%) | 573(67.4%) | 25.18 ± 28.72 | |||
| Menopause (frequency, percentile) | Yes | 289 | 96(33.2%) | 193(66.8%) | < 0.001 | 24.75 ± 30.37 | < 0.001 |
| No | 113 | 63(55.8%) | 50(44.2%) | 12.66 ± 17.39 | |||
| HRT (frequency, percentile) | Yes | 78 | 34(43.6%) | 44(56.4%) | 0.014 | 16.58 ± 20.28 | 0.004 |
| No | 930 | 280(30.1%) | 650(69.9%) | 26.17 ± 28.71 | |||
| MI (frequency, percentile) | Yes | 73 | 8(11.0%) | 65(89.0%) | < 0.001 | 40.80 ± 32.14 | < 0.001 |
| No | 935 | 306(32.7%) | 629(67.3%) | 24.23 ± 27.59 | |||
| ACS (frequency, percentile) | Yes | 392 | 95(24.2%) | 297(75.8%) | < 0.001 | 29.00 ± 29.88 | 0.001 |
| No | 616 | 219(35.6%) | 397(64.4%) | 23.15 ± 26.95 | |||
| Type of presentation (frequency, percentile) | STEMI | 77 | 9(11.7%) | 68(88.3%) | < 0.001 | 33.51 ± 27.41 | < 0.001\ |
| NSTEMI | 51 | 6(11.8%) | 45(88.2%) | 41.15 ± 35.58 | |||
| Unstable Angina | 35 | 6(17.1%) | 29(82.9%) | 30.22 ± 23.55 | |||
| Stable Angina | 707 | 237(33.5%) | 470(66.5%) | 24.05 ± 28.07 | |||
| Others | 138 | 56(40.6%) | 82(59.4%) | 20.94 ± 25.05 | |||
| WC (cm) | < 102 or < 88 | 367 | 89(24.3%) | 278(75.7%) | < 0.001 | 27.73 ± 26.98 | 0.050 |
| > = 102 or > =88 | 641 | 225(35.1%) | 416(64.9%) | 24.11 ± 28.90 | |||
| W/HR | <=0.9 or < =0.85 | 28 | 10(35.7%) | 18(64.3%) | 0.597 | 15.92 ± 15.11 | 0.071 |
| > 0.9 or > 0.85 | 980 | 304(31.0%) | 676(69.0%) | 25.70 ± 28.50 | |||
| W/HtR | < 0.5 | 60 | 14(23.3%) | 46(76.7%) | 0.178 | 25.62 ± 24.34 | 0.956 |
| > = 0.5 | 948 | 300(31.6%) | 648(68.4%) | 25.42 ± 28.50 | |||
| BMI (kg/m2) | < 25 | 226 | 53(23.5%) | 173(76.5%) | < 0.001 | 27.15 ± 27.00 | 0.015 |
| 25–29 | 465 | 137(29.5%) | 328(70.5%) | 27.18 ± 28.65 | |||
| > = 30 | 317 | 124(39.1%) | 193(60.9%) | 21.62 ± 28.26 | |||
| HLP ((frequency, percentile) | Yes | 234 | 57(24.4%) | 177(75.6%) | 0.010 | 31.11 ± 31.65 | < 0.001 |
| No | 774 | 257(33.2%) | 517(66.8%) | 23.71 ± 26.93 | |||
HTN Hypertension, DM Diabetes mellitus, CABG Coronary artery bypass graft, PCI Percutaneous coronary intervention, ACS Acute coronary syndrome, HF Heart failure, FH Family history, HRT Hormone replacement therapy, MI Myocardial infarction, STEMI ST-elevation myocardial infarction, NSTEMI Non ST-elevation myocardial infarction, WC Waist circumference, W/HR Waist to hip ratio, W/HtR Waist to height ratio, BMI Body mass index, HLP Hyperlipidemia, CAD Coronary artery disease